LLS Team in Training Celebrates 25 Years

This year marks the 25th year for one of the Leukemia and Lymphoma Society's flagship fundraising campaigns, Team In Training (TNT).

Called the world's first and largest endurance sports training program, TNT works by offering participants a choice of more than 200 accredited national and local events for which to train.

In exchange for raising funds for the LLS, and in an effort to achieve their goals in whichever event they choose, participants receive four or five months worth of personalized training by certified professional fitness coaches.

More than 570,000 people have participated in TNT over the past 25 years, helping to raise more than $875 million towards finding effective treatments and cures for blood cancers.

Said George Omiros, executive vice president, chief campaign and field development officer of LLS:

Not only have [TNT participants] had an unforgettable experience and opportunity to reach personal goals, but these committed individuals have brought us closer to the ultimate finish line: the end of blood cancers. Team In Training has played a tremendous role in the success of LLS, in helping us fund leading scientists and researchers to discover novel, breakthrough blood cancer treatments and cures.

TNT was launched ostensibly in 1988 by New Yorker Bruce Cleland. He formed a team to train for and run the New York City Marathon, which would also raise funds for the LLS in honor of his daughter Georgia, who, at just 2 years old, had been diagnosed with acute lymphocytic leukemia (ALL), the most common form of cancer to afflict children.

Said Cleland:

I was trying to get past the helplessness and fear I felt as a result of my daughter's deadly diagnosis. When Georgia was diagnosed, the five-year survival rate was only a shocking 60 percent. A desire to help her and others like her was my fuel. Day after day it literally got me up on my feet, out on the road and eventually over the finish line along with my wonderful TNT teammates.

His team of 38 runners raised an astonishing $320,000 for the LLS and gave rise to this incredible program, which runs throughout the year.

As for his daughter, today Georgia is 29, cancer-free, and currently training for her fourth half-marathon by way of the campaign her father began 25 years ago.

Source: LLS

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap